CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Revenues:
Product revenue, net	$ 62,175	$ 0	$ 76,813	$ 0
Operating expenses:
Cost of sales	2,152	0	2,788	0
Research and development	68,742	70,951	211,070	201,710
Selling, general and administrative	107,585	27,583	293,834	61,610
Total operating expenses	178,479	98,534	507,692	263,320
Loss from operations	(116,304)	(98,534)	(430,879)	(263,320)
Interest income	13,019	3,298	35,575	10,625
Interest expense	(3,679)	(3,504)	(11,172)	(8,741)
Net loss	$ (106,964)	$ (98,740)	$ (406,476)	$ (261,436)
Net loss per common share:
Basic net loss per common share (in dollars per share)	$ (4.92)	$ (5.34)	$ (19.31)	$ (14.27)
Diluted net loss per common share (in dollars per share)	$ (4.92)	$ (5.34)	$ (19.31)	$ (14.27)
Basic weighted average number of common shares outstanding (in shares)	21,745,929	18,476,414	21,052,544	18,326,154
Diluted weighted average number of common shares outstanding (in shares)	21,745,929	18,476,414	21,052,544	18,326,154